OXFD - Oxford Immunotec Global PLC

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Oxford Immunotec Global PLC

143 Park Drive
Milton Park
Abingdon OX14 4SE
United Kingdom
44 1235 442 780
http://www.oxfordimmunotec.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees215

Key Executives

NameTitlePayExercisedYear Born
Dr. Peter Wrighton-SmithCEO & Exec. Director669.26k1.51M1974
Mr. Stefan C. LinnChief Operating Officer614kN/A1965
Mr. Matthew T.E. McLaughlinChief Financial OfficerN/AN/A1977
Ms. Karen C. KoskiVP of Strategy & Investor RelationsN/AN/AN/A
Dr. Peter EdwardsonSr. VP & Head of Blood ScreeningN/AN/A1962
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States. It develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. The company develops and markets T-SPOT.TB test used to test for tuberculosis. It is also developing C6 Borrelia burgdorferi (Lyme) ELISA kit, which measures Lyme specific antibodies; and T-SPOT.CMV test that utilizes its T-SPOT technology platform to measure the strength of a patient's cellular immune response to antigens specific to cytomegalovirus (CMV), as well as provides information for informing management strategies of patients at risk of CMV infection and disease, such as transplant patients. The company markets its T-SPOT.TB test through a direct sales force in the United States, certain European countries, and Japan, as well as through distributors internationally. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

Corporate Governance

Oxford Immunotec Global PLC’s ISS Governance QualityScore as of April 1, 2019 is 5. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 5; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.